🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 12 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/10/2024 46,80 47,03 45,51 45,96 -2,15% 3,25% 439.600
18/10/2024 47,20 47,53 46,69 46,97 -0,11% 1,78% 588.700
17/10/2024 47,11 47,54 46,68 47,02 +0,06% 1,81% 554.500
16/10/2024 47,78 48,02 46,77 46,99 -1,36% 2,61% 614.800
15/10/2024 46,62 48,32 46,59 47,64 +2,78% 3,72% 600.800
14/10/2024 44,96 46,90 44,77 46,35 +2,82% 4,74% 601.900
11/10/2024 43,56 45,34 43,56 45,08 +3,42% 4,09% 600.100
10/10/2024 43,64 44,53 43,18 43,59 -1,34% 3,08% 686.300
09/10/2024 43,95 44,61 43,33 44,18 +0,50% 2,91% 605.800
08/10/2024 44,15 44,67 43,92 43,96 +0,37% 1,70% 384.300
07/10/2024 44,18 44,24 42,78 43,80 -1,28% 3,30% 499.600
04/10/2024 44,63 45,24 44,16 44,37 +0,07% 2,42% 313.600
03/10/2024 44,91 45,24 43,93 44,34 -1,42% 2,91% 384.500
02/10/2024 44,15 45,06 43,56 44,98 +1,37% 3,40% 453.600
01/10/2024 44,81 45,33 43,41 44,37 -1,40% 4,27% 792.700
30/09/2024 44,02 45,38 44,01 45,00 +0,99% 3,10% 543.300
27/09/2024 45,24 45,27 44,30 44,56 -0,82% 2,13% 661.900
26/09/2024 46,25 46,78 44,64 44,93 -2,62% 4,64% 531.200
25/09/2024 47,00 47,66 46,10 46,14 -0,94% 3,31% 812.900
24/09/2024 47,10 47,61 46,16 46,58 +0,93% 3,08% 773.100
23/09/2024 47,24 47,85 45,27 46,15 -2,49% 5,46% 730.400
20/09/2024 46,01 47,45 45,59 47,33 +3,07% 4,05% 3.265.300
19/09/2024 45,93 46,55 45,05 45,92 +2,57% 3,27% 647.800
18/09/2024 45,08 46,36 44,40 44,77 -0,31% 4,35% 526.200
17/09/2024 46,35 46,50 44,62 44,91 -2,79% 4,06% 661.600
16/09/2024 47,17 48,00 45,50 46,20 -1,74% 5,30% 699.500
13/09/2024 45,49 47,15 45,42 47,02 +3,00% 3,80% 621.100
12/09/2024 45,25 45,82 44,47 45,65 +1,92% 2,98% 545.200
11/09/2024 44,55 45,15 43,96 44,79 -0,29% 2,67% 558.200
10/09/2024 44,60 45,07 44,37 44,92 +0,74% 1,57% 555.200